Status:

UNKNOWN

Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth

Lead Sponsor:

Rigshospitalet, Denmark

Conditions:

Xerostomia Due to Radiotherapy

Hyposalivation

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

Brief Summary

An investigator-initiated, non-randomized, open label study to investigate the safety, feasibility and tolerability of intraglandular injection of allogeneic mesenchymal stem/stromal cells (MSCs) into...

Detailed Description

Patients with previous oropharyngeal cancer and radiation-induced hyposalivation and xerostomia (dry mouth syndrome) will receive intraglandular injections of allogeneic adipose-derived MSCs into the ...

Eligibility Criteria

Inclusion

  • Age between 18-75 years
  • Previous radiotherapy +/- chemotherapy for OPSCC stage I- II (UICC-8, 2017)
  • 2 years' follow-up without recurrence
  • Clinically reduced salivation and hyposalivation, evaluated by a screening
  • Unstimulated salivary flow rate between 0.2mL/min and 0.05mL/min
  • Grade 2-3 xerostomia (CTCAEv5.0)
  • WHO Performance status (PS) 0-1
  • Informed consent

Exclusion

  • Any cancer in the previous 4 years (not including OPSCC and basocellular carcinomas)
  • Xerogenic medications
  • Penicillin or Streptomycin allergy
  • Any other diseases of the salivary glands, e.g. Sjögren's syndrome or sialolithiasis
  • Previous parotid or submandibular gland surgery
  • Previous treatment with any type of stem cells
  • Breastfeeding, Pregnancy or planned pregnancy within the next 2 years
  • Smoking within the previous 6 months.
  • Alcohol abuse (consumption must not exceed 7 units/week for women and 14 units/week for men (Danish National board health alcohol guidelines3)
  • Any other disease/condition judged by the investigator to be grounds for exclusion

Key Trial Info

Start Date :

March 18 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2025

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03874572

Start Date

March 18 2019

End Date

December 1 2025

Last Update

January 29 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Department of Otolaryngology, Rigshospitalet, University Hospital of Copenhagen

Copenhagen, Denmark, 2100

2

Department of Otolaryngology, Rigshospitalet

Copenhagen, Denmark, 2100